COVID-19 vaccine for babies and toddlers could be approved early 2022, chief public health officer says – CBC

Pfizer-BioNTech, Moderna testing vaccine for those starting at 6 months

Nov 25, 2021

Canada’s chief public health officer says COVID-19 vaccines for babies and toddlers could be approved early in the new year, depending on how clinical trials play out.

In an interview with CBC Radio-Canada, Dr. Theresa Tam said a vaccine for some of Canada’s youngest people could be a turning point in the fight against COVID-19.

“Children do have a robust immune system and I expect that they will mount a good immune response to the vaccine as well,” she said

“And for their parents as well, it’s sort of offering them some further hope.”

In a major vaccine milestone, children aged five to 11 started to receive their first doses this week after Health Canada approved Pfizer-BioNTech’s vaccine for that age group. Meanwhile, that company is running clinical trials for those aged six months to just under five years.

Read more: https://www.cbc.ca/news/politics/tam-vaccine-babies-toddlers-1.6262091

NationTalk Partners & Sponsors Learn More